| scholarly article | Q13442814 |
| P50 | author | Heng Zhu | Q83131550 |
| P2093 | author name string | Li Ding | |
| Hua Wang | |||
| Qian Wang | |||
| Xin Li | |||
| Ning Mao | |||
| Chu-Tse Wu | |||
| Yu-Xing Wang | |||
| Zhi-Dong Zhao | |||
| Shou-Bin Ning | |||
| P2860 | cites work | Intestinal T cell profiling in Inflammatory Bowel Disease; linking T cell subsets to disease activity and disease course. | Q50049064 |
| Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease | Q51132725 | ||
| Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis. | Q51210577 | ||
| Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model. | Q52595779 | ||
| Radial shockwave treatment promotes human mesenchymal stem cell self-renewal and enhances cartilage healing. | Q52727578 | ||
| [Effect of intercellular adhesion molecule-1 on the migration in vitro of murine mesenchymal stem cells and its related mechanism]. | Q54357438 | ||
| Overexpressing p130/E2F4 in mesenchymal stem cells facilitates the repair of injured alveolar epithelial cells in LPS-induced ARDS mice | Q64060110 | ||
| Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease | Q81659326 | ||
| A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone | Q83131551 | ||
| Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation | Q85121641 | ||
| Inflammatory bowel disease | Q88097800 | ||
| Stem Cell Therapies for Inflammatory Bowel Disease | Q92898971 | ||
| Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care | Q93093495 | ||
| Understanding and Preventing the Global Increase of Inflammatory Bowel Disease | Q30243958 | ||
| Inflammatory bowel disease: cause and immunobiology | Q33284507 | ||
| The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis | Q33577019 | ||
| Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression | Q33898626 | ||
| Stem cells as potential therapeutic targets for inflammatory bowel disease | Q33975300 | ||
| Intercellular adhesion molecule-1 inhibits osteogenic differentiation of mesenchymal stem cells and impairs bio-scaffold-mediated bone regeneration in vivo | Q34331075 | ||
| Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis? | Q34779125 | ||
| Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation | Q35190547 | ||
| Mesenchymal stem cell effects on T-cell effector pathways. | Q35558505 | ||
| Integrins and T cell-mediated immunity | Q35698435 | ||
| Emerging roles for multipotent, bone marrow-derived stromal cells in host defense | Q35802197 | ||
| Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy | Q36055845 | ||
| Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases | Q36818290 | ||
| Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells | Q36998218 | ||
| Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE. | Q37326277 | ||
| The global burden of IBD: from 2015 to 2025. | Q38577572 | ||
| Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages | Q38607615 | ||
| Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1. | Q38650560 | ||
| Current and emerging therapeutic targets for IBD. | Q38763559 | ||
| Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. | Q39186262 | ||
| Potential therapeutic utility of mesenchymal stem cells in inflammatory bowel disease in mice. | Q45937584 | ||
| Environmental triggers in IBD: a review of progress and evidence. | Q46026239 | ||
| Induction of TNBS colitis in mice | Q46630014 | ||
| Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality? | Q47947480 | ||
| Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases. | Q48234353 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P304 | page(s) | 267 | |
| P577 | publication date | 2019-08-23 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens | |
| P478 | volume | 10 |
| Q91995043 | GVHD-derived plasma as a priming strategy of mesenchymal stem cells |
| Q99712184 | Genetic Engineering as a Strategy to Improve the Therapeutic Efficacy of Mesenchymal Stem/Stromal Cells in Regenerative Medicine |
| Q91788765 | Growth Factor Gene-Modified Mesenchymal Stem Cells in Tissue Regeneration |
Search more.